Exploratory biomarker analysis of RAS/BRAF somatic mutations and gene expression signatures for predicting treatment effects of aflibercept in the velour trial. - Pu T; Peddle AM; Wirapati P; Tsantoulis P; Wu Q; Hong Y; Samuel L; Desai J; Riener M; Saridaki Z; Cunningham D; Tejpar S (NPJ precision oncology, 2026)